Figure 2

Adjusted hazard ratios of clinical outcomes for the use of iron-based phosphate binders in comparison with those for only non-iron-based phosphate binders. CVD cardiovascular disease.

Adjusted hazard ratios of clinical outcomes for the use of iron-based phosphate binders in comparison with those for only non-iron-based phosphate binders. CVD cardiovascular disease.